Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

Chen Y, Li S, Brown C, Cheatham S, Castro RA, Leabman MK, Urban TJ, Chen L, Yee SW, Choi JH, Huang Y, Brett CM, Burchard EG, Giacomini KM.

Pharmacogenet Genomics. 2009 Jul;19(7):497-504. doi: 10.1097/FPC.0b013e32832cc7e9.

PMID:
19483665
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.

Eckardt JR, Bentsion DL, Lipatov ON, Polyakov IS, Mackintosh FR, Karlin DA, Baker GS, Breitz HB.

J Clin Oncol. 2009 Apr 20;27(12):2046-51. doi: 10.1200/JCO.2008.19.3235. Epub 2009 Mar 16.

PMID:
19289620
[PubMed - indexed for MEDLINE]
Free Article
3.

Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.

Zolk O, Solbach TF, K├Ânig J, Fromm MF.

Drug Metab Dispos. 2009 Jun;37(6):1312-8. doi: 10.1124/dmd.108.023762. Epub 2009 Feb 27.

PMID:
19251820
[PubMed - indexed for MEDLINE]
Free Article
4.

New-generation platinum agents for solid tumors.

Shah N, Dizon DS.

Future Oncol. 2009 Feb;5(1):33-42. doi: 10.2217/14796694.5.1.33. Review.

PMID:
19243296
[PubMed - indexed for MEDLINE]
5.

Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.

Yokoo S, Masuda S, Yonezawa A, Terada T, Katsura T, Inui K.

Drug Metab Dispos. 2008 Nov;36(11):2299-306. doi: 10.1124/dmd.108.023168. Epub 2008 Aug 18.

PMID:
18710896
[PubMed - indexed for MEDLINE]
Free Article
6.

Developments in the treatment of non-small cell lung cancer.

Gkiozos I, Charpidou A, Syrigos K.

Anticancer Res. 2007 Jul-Aug;27(4C):2823-7. Review.

PMID:
17695454
[PubMed - indexed for MEDLINE]
Free Article
7.

The resurgence of platinum-based cancer chemotherapy.

Kelland L.

Nat Rev Cancer. 2007 Aug;7(8):573-84. Epub 2007 Jul 12. Review.

PMID:
17625587
[PubMed - indexed for MEDLINE]
8.

Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.

Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K.

Biochem Pharmacol. 2007 Aug 1;74(3):477-87. Epub 2007 Mar 12.

PMID:
17582384
[PubMed - indexed for MEDLINE]
9.

Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family.

Chen Y, Zhang S, Sorani M, Giacomini KM.

J Pharmacol Exp Ther. 2007 Aug;322(2):695-700. Epub 2007 May 10.

PMID:
17495125
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM.

J Clin Invest. 2007 May;117(5):1422-31.

PMID:
17476361
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

JAMA patient page. Lung cancer.

Zeller JL, Lynm C, Glass RM.

JAMA. 2007 Mar 7;297(9):1022. No abstract available.

PMID:
17341716
[PubMed - indexed for MEDLINE]
12.

Chemotherapy resistance and oncogene expression in non-small cell lung cancer.

d'Amato TA, Landreneau RJ, Ricketts W, Huang W, Parker R, Mechetner E, Yu IR, Luketich JD.

J Thorac Cardiovasc Surg. 2007 Feb;133(2):352-63. Epub 2007 Jan 9.

PMID:
17258563
[PubMed - indexed for MEDLINE]
13.

Organic cation transporters are determinants of oxaliplatin cytotoxicity.

Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X, Lippard SJ, Giacomini KM.

Cancer Res. 2006 Sep 1;66(17):8847-57.

PMID:
16951202
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).

Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K.

J Pharmacol Exp Ther. 2006 Nov;319(2):879-86. Epub 2006 Aug 16.

PMID:
16914559
[PubMed - indexed for MEDLINE]
Free Article
15.

Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies.

Battle AR, Choi R, Hibbs DE, Hambley TW.

Inorg Chem. 2006 Aug 7;45(16):6317-22.

PMID:
16878941
[PubMed - indexed for MEDLINE]
16.

Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.

Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM.

Mol Cancer Ther. 2005 Mar;4(3):351-60.

PMID:
15767544
[PubMed - indexed for MEDLINE]
Free Article
17.

Platinums in lung cancer: sufficient or necessary?

Bunn PA Jr.

J Clin Oncol. 2005 May 1;23(13):2882-3. Epub 2005 Feb 22. No abstract available.

PMID:
15728220
[PubMed - indexed for MEDLINE]
Free Article
18.

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.

Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT.

Mol Cancer Ther. 2004 Dec;3(12):1543-9. Erratum in: Mol Cancer Ther. 2005 May;4(5):864.

PMID:
15634647
[PubMed - indexed for MEDLINE]
Free Article
19.

Platinum drugs in the treatment of non-small-cell lung cancer.

Cosaert J, Quoix E.

Br J Cancer. 2002 Oct 7;87(8):825-33. Review.

PMID:
12373594
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.

Ishida S, Lee J, Thiele DJ, Herskowitz I.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302. Epub 2002 Oct 7.

PMID:
12370430
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk